Catalyst Wire Dossier Catalyst Wire Dossier

IONIS-HBVRx

IONIS-HBVRx · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IONIS-HBVRx, covering 2020-12-21 to 2020-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection [Phase 2]

See pricing